DescriptionSources: https://cameochemicals.noaa.gov/chemical/3468 | https://www.ncbi.nlm.nih.gov/pubmed/2135524https://books.google.ru/books?id=vxtxWneRBN4C&pg=PA1103&#v=onepage&q&f=falsehttps://mistralhowto.wordpress.com/2012/03/12/what-is-pigment-yellow-42-and-what-is-it-used-for/ | http://sensientfoodcolors.com/en-us/confection/iron-oxides-approved-by-the-fda/ | https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=73.2250 | https://www.drugs.com/inactive/ferric-oxide-yellow-381.htmlhttp://www.mfc.co.jp/english/eng/product/sanferol/pdf/fls_gras_notice.pdfhttps://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205874Orig1s000PharmR.pdfhttp://www.edta-chelate.com/ferric-ammonium-edta-liquid--1640836.htmlCurator's Comment: description was created based on several sources, including
http://www.mfc.co.jp/english/eng/product/sanferol/index.html
Sources: https://cameochemicals.noaa.gov/chemical/3468 | https://www.ncbi.nlm.nih.gov/pubmed/2135524https://books.google.ru/books?id=vxtxWneRBN4C&pg=PA1103&#v=onepage&q&f=falsehttps://mistralhowto.wordpress.com/2012/03/12/what-is-pigment-yellow-42-and-what-is-it-used-for/ | http://sensientfoodcolors.com/en-us/confection/iron-oxides-approved-by-the-fda/ | https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=73.2250 | https://www.drugs.com/inactive/ferric-oxide-yellow-381.htmlhttp://www.mfc.co.jp/english/eng/product/sanferol/pdf/fls_gras_notice.pdfhttps://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205874Orig1s000PharmR.pdfhttp://www.edta-chelate.com/ferric-ammonium-edta-liquid--1640836.html
Curator's Comment: description was created based on several sources, including
http://www.mfc.co.jp/english/eng/product/sanferol/index.html
Ferric Ammonium EDTA Solution is normally used as a photographic chemical for a bleaching agent in the process of colour washing. It is also used as a complexing, and oxidizing agent & as a fertilizer and catalyst. EDTA acid are colourless, water-soluble solid that are widely used to dissolve scale. The usefulness of these ammonium salts arise because of its role as a chelating agent, i.e. its ability to "sequester" metal ions such as Ca2+ and Fe3+.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0006927 |
|||
Target ID: CHEMBL2364184 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | SANFEROL Approved UseIt has also been reported that SFC preparation improved iron deficiency in a pregnant woman with iron deficiency anemia whose hemoglobin level had not increased after administration of other iron preparations such as ferrous fumarate. A dairy supplemental dose of SFC improved iron deficiency in young women with iron deficiency. |
|||
| Inactive ingredient | Oxycontin Approved UseOxyContin is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Launch Date1998 |
|||
| Palliative | AURYXIA Approved UseFerric Citrate is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. Launch Date2014 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Phosphorus recovery from biogas slurry by ultrasound/H2O2 digestion coupled with HFO/biochar adsorption process. | 2017-02 |
|
| Superior electrochemical performance of N-doped nanocrystalline FeF3/C with a single-step solid-state process. | 2016-10-04 |
|
| Heme Binding by Corynebacterium diphtheriae HmuT: Function and Heme Environment. | 2015-11-03 |
|
| Microwave assisted convenient one-pot synthesis of coumarin derivatives via Pechmann condensation catalyzed by FeF3 under solvent-free conditions and antimicrobial activities of the products. | 2014-08-26 |
|
| FeF(3) catalyzed cascade C-C and C-N bond formation: synthesis of differentially substituted triheterocyclic benzothiazole functionalities under solvent-free condition. | 2014-05 |
|
| Finnish wallpaper pigments in the 18th-19th century: presence of KFe3(CrO4)2(OH)6 and odd pigment mixtures. | 2013-04 |
|
| Thermal behavior study and decomposition kinetics of amiodarone hydrochloride under isothermal conditions. | 2011-06 |
|
| Fabrication of FeF3 Nanoflowers on CNT branches and their application to high power lithium rechargeable batteries. | 2010-12-07 |
|
| Interaction of omapatrilat with FD&C Blue No. 2 lake during dissolution of modified release tablets. | 2007-07-18 |
|
| Non-invasive and non-destructive micro-XRF and micro-Raman analysis of a decorative wallpaper from the beginning of the 19th century. | 2007-02 |
|
| New phosphate binding agents: ferric compounds. | 1999-06 |
|
| Effect of physical exercise and vitamin C on absorption of ferric sodium citrate. | 1996-12 |
|
| Carcinogenicity studies on natural and man-made fibres with the intraperitoneal test in rats. | 1989 |
|
| Contact dermatitis to yellow iron oxide. | 1985-08 |
|
| Biological availability of iron supplements for rats, chicks and humans. | 1976-02 |
|
| The absorption of iron as supplements in infant cereal and infant formulas. | 1975-05 |
|
| The formation of ferritin from apoferritin. Catalytic action of apoferritin. | 1973-10 |
|
| The formation of ferritin from apoferritin. Kinetics and mechanism of iron uptake. | 1972-01 |
|
| [Effects of ferric fluoride compounds on dental enamel]. | 1954-11-15 |
Sample Use Guides
In Vivo Use Guide
Curator's Comment: Iron oxides black, red and yellow are intended to be used as colourants in feedingstuffs for all animal species without dose or age restriction. The applicant recommends 500–1,200 mg/kg of the additives in complete (and complementary) feedingstuffs as standard dose. http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2016.4482/full
Unknown
Route of Administration:
Unknown
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
B03AB02
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
||
|
NDF-RT |
N0000006237
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
||
|
WHO-VATC |
QB03AB02
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
||
|
NDF-RT |
N0000006237
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
||
|
NDF-RT |
N0000177913
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
||
|
WHO-ATC |
B03AC02
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
||
|
NDF-RT |
N0000006237
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000084883
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
PRIMARY | |||
|
232-464-7
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
PRIMARY | |||
|
24909
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
PRIMARY | RxNorm | ||
|
DB09146
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
PRIMARY | |||
|
C65963
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
PRIMARY | |||
|
Iron sucrose
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
PRIMARY | |||
|
SUB16439MIG
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
PRIMARY | |||
|
91663255
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
PRIMARY | |||
|
FZ7NYF5N8L
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
PRIMARY | |||
|
FZ7NYF5N8L
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
PRIMARY | |||
|
C1505
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
CONCEPT | Dietary Supplement | ||
|
Iron Sucrose
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
PRIMARY | |||
|
DTXSID70895107
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
PRIMARY | |||
|
KK-117
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
PRIMARY | |||
|
8047-67-4
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
PRIMARY | |||
|
m6415
Created by
admin on Tue Apr 01 20:34:49 GMT 2025 , Edited by admin on Tue Apr 01 20:34:49 GMT 2025
|
PRIMARY | Merck Index |
ACTIVE MOIETY
SUBSTANCE RECORD
